Replies to post #88895 on Biotech Values

[genisi]

Allergan Inc (AGN.N) bought co-promotion rights on Map Pharmaceuticals Inc's (MAPP.O) experimental treatment for acute migraine for $60 million in upfront payment, in a move to expand its migraine franchise.

The two companies will co-promote the drug, Levadex, to neurologists and pain specialists in the United States, pending regulatory approval.

http://www.reuters.com/article/2011/01/31/allergan-idUSSGE70U0CE20110131?feedType=RSS&feedName=rbssHealthcareNews&rpc=43